Could researchers found the magic bullet for cancer? NIH thinks possibly that they have.
Epigenetic marks seen across multiple cancers may serve as a biomarker for identifying solid tumor DNA in blood samples.
Pan-Cancer Epigenetic Signature Readable in Circulating Tumor DNA
Posted in biotech/medical, genetics